AbCellera Biologics Inc. monthly returns
AbCellera Biologics Inc. has averaged 0.62% per month, positive in 44% of months. Month-by-month returns for AbCellera Biologics Inc. (ABCL) below, through October 22, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
AbCellera Biologics Inc. monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | -22.1% | |
| Sep 2026 | +27.1% | |
| Aug 2026 | +101.1% | |
| Jul 2026 | -27.3% | |
| Jun 2026 | +27.2% | |
| May 2026 | +48.7% | |
| Apr 2026 | +18.9% | |
| Mar 2026 | -3.3% | |
| Feb 2026 | -0.3% | |
| Jan 2026 | +5.8% | |
| Dec 2025 | -8.3% | |
| Nov 2025 | -32.8% | |
| Oct 2025 | +10.3% | |
| Sep 2025 | +20.3% | |
| Aug 2025 | -6.5% | |
| Jul 2025 | +30.3% | |
| Jun 2025 | +69.8% | |
| May 2025 | -22.6% | |
| Apr 2025 | +17.0% | |
| Mar 2025 | -13.7% | |
| Feb 2025 | -18.5% | |
| Jan 2025 | +8.2% | |
| Dec 2024 | -2.7% | |
| Nov 2024 | +10.3% | |
| Oct 2024 | +5.0% | |
| Sep 2024 | +1.6% | |
| Aug 2024 | -21.5% | |
| Jul 2024 | +10.1% | |
| Jun 2024 | -24.5% | |
| May 2024 | +3.7% | |
| Apr 2024 | -16.6% | |
| Mar 2024 | -10.3% | |
| Feb 2024 | -1.2% | |
| Jan 2024 | -10.5% | |
| Dec 2023 | +21.2% | |
| Nov 2023 | +14.6% | |
| Oct 2023 | -10.7% | |
| Sep 2023 | -15.6% | |
| Aug 2023 | -29.5% | |
| Jul 2023 | +19.7% | |
| Jun 2023 | -7.3% | |
| May 2023 | +2.8% | |
| Apr 2023 | -10.1% | |
| Mar 2023 | -10.2% | |
| Feb 2023 | -20.2% | |
| Jan 2023 | +3.9% | |
| Dec 2022 | -21.3% | |
| Nov 2022 | +8.8% | |
| Oct 2022 | +19.6% | |
| Sep 2022 | -7.4% | |
| Aug 2022 | +6.4% | |
| Jul 2022 | -5.7% | |
| Jun 2022 | +39.8% | |
| May 2022 | -0.7% | |
| Apr 2022 | -21.3% | |
| Mar 2022 | +11.9% | |
| Feb 2022 | -3.1% | |
| Jan 2022 | -37.1% | |
| Dec 2021 | -4.4% | |
| Nov 2021 | -4.8% | |
| Oct 2021 | -21.6% | |
| Sep 2021 | +19.4% | |
| Aug 2021 | +10.6% | |
| Jul 2021 | -31.0% | |
| Jun 2021 | -18.0% | |
| May 2021 | +0.7% | |
| Apr 2021 | -21.5% | |
| Mar 2021 | -9.9% | |
| Feb 2021 | -28.6% | |
| Jan 2021 | +31.3% |
Monthly total return (since Nov 2021)#
AbCellera Biologics Inc. returns by calendar month#
Every month of every year since 2021, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
October 2026 so far: -22.07% — 6th of 6 Octobers since 2021 at the last close; the average October returned +0.5%.
| Month | −105%0+105% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | +0.3% | +4.9% | 67% | +31.3% 2021 | -37.1% 2022 | |
| Feb | -12.0% | -10.8% | 0% | -0.3% 2026 | -28.6% 2021 | |
| Mar | -5.9% | -10.1% | 17% | +11.9% 2022 | -13.7% 2025 | |
| Apr | -5.6% | -13.3% | 33% | +18.9% 2026 | -21.5% 2021 | |
| May | +5.4% | +1.7% | 67% | +48.7% 2026 | -22.6% 2025 | |
| Jun | +14.5% | +10.0% | 50% | +69.8% 2025 | -24.5% 2024 | |
| Jul | -0.7% | +2.2% | 50% | +30.3% 2025 | -31.0% 2021 | |
| Aug | +10.1% | -0.1% | 50% | +101.1% 2026 | -29.5% 2023 | |
| Sep | +7.6% | +10.5% | 67% | +27.1% 2026 | -15.6% 2023 | |
| Oct | +0.5% | +5.0% | 60% | +19.6% 2022 | -21.6% 2021 | |
| Nov | -0.8% | +8.8% | 60% | +14.6% 2023 | -32.8% 2025 | |
| Dec | -3.1% | -4.4% | 20% | +21.2% 2023 | -21.3% 2022 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from ABCL's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is AbCellera Biologics Inc.'s average monthly return?
- AbCellera Biologics Inc. (ABCL) has averaged about 0.62% per month, positive in roughly 44% of months. The best month was Aug 2026 (+101.1%) and the worst was Jan 2022 (-37.1%).